Endoproteolytic processing of the Ebola virus envelope glycoprotein: Cleavage is not required for function

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1419-1426

  Wool Lewis, Rouven J ^a   Bates, Paul ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FURIN; GLYCOPROTEIN; PROTEINASE; VIRUS PROTEIN;

ARTICLE; EBOLA VIRUS; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HYPOTHESIS; MURINE LEUKEMIA VIRUS; PARAMYXOVIRUS; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RETROVIRUS; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; VIRULENCE; VIRUS ENVELOPE;

EID: 0032949982     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1419-1426.1999     Document Type: Article

References (49)

1. Bates, P. Unpublished observations.
2. Bos, E. C., L. Heijnen, W. Luytjes, and W. J. Spaan. 1995. Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology 214:453-463.
3. Bos, E. C., W. Luytjes, and W. J. Spaan. 1997. The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity. J. Virol. 71:9427-9433.
4. Bosch, F. X., W. Garten, H. D. Klenk, and R. Rott. 1981. Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses. Virology 113:725-735.
5. Bosch, F. X., M. Orlich, H. D. Klenk, and R. Rott. 1979. The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology 95:197-207.
6. Bukreyev, A., V. E. Volchkov, V. M. Blinov, and S. V. Netesov. 1993. The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins. FEBS Lett. 323:183-187.
7. Damico, R. L., J. Crane, and P. Bates. 1998. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA 95:2580-2585.
8. Decroly, E., M. Vandenbranden, J. M. Ruysschaert, J. Cogniaux, G. S. Jacob, S. C. Howard, G. Marshall, A. Kompelli, A. Basak, F. Jean, et al. 1994. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp120 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J. Biol. Chem. 269:12240-12247.
9. Dong, J. Y., J. W. Dubay, L. G. Perez, and E. Hunter. 1992. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 66:865-874.
10. Elliott, L. H., M. P. Kiley, and J. B. McCormick. 1985. Descriptive analysis of Ebola virus proteins. Virology 147:169-176.
11. Freed, E. O., D. J. Myers, and R. Risser. 1989. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J. Virol. 63:4670-4675.
12. Freed, E. O., and R. Risser. 1987. The role of envelope glycoprotein processing in murine leukemia virus infection. J. Virol. 61:2852-2856.
13. Gallaher, W. R., J. M. Ball, R. F. Garry, M. C. Griffin, and R. C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5:431-440.
14. Gilbert, J. M., P. Bates, H. E. Varmus, and J. M. White. 1994. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J. Virol. 68:5623-5628.
15. Gilbert, J. M., L. D. Hernandez, J. W. Balliet, P. Bates, and J. M. White. 1995. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:7410-7415.
16. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
17. Gu, M., J. Rappaport, and S. H. Leppla. 1995. Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett. 365:95-97.
18. Guo, H. G., F. M. Veronese, E. Tschachler, R. Pal, V. S. Kalyanaraman, R. C. Gallo, and M. S. Reitz, Jr. 1990. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Virology 174:217-224.
19. Hingley, S. T., I. Leparc-Goffart, and S. R. Weiss. 1998. The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes. J. Virol. 72:1606-1609.
20. Horimoto, T., K. Nakayama, S. P. Smeekens, and Y. Kawaoka. 1994. Proprotein-proccssing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 68:6074-6078.
21. Hosaka, M., M. Nagahama, W. S. Kim, T. Watanabe, K. Hatsuzawa, J. Ikemizu, K. Murakami, and K. Nakayama. 1991. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J. Biol. Chem. 266:12127-12130.
22. Hunter, E., E. Hill, M. Hardwick, A. Bhown, D. E. Schwartz, and R. Tizard. 1983. Complete sequence of the Rous sarcoma virus env gene: identification of structural and functional regions of its product. J. Virol. 46:920-936.
23. Inocencio, N. M., J. F. Sucic, J. M. Moehring, M. J. Spence, and T. J. Moehring. 1997. Endoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycoprotcins in CHO-K1 cells. J. Biol. Chem. 272:1344-1348.
24. Kawaoka, Y., and R. G. Webster. 1988. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl. Acad. Sci. USA 85:324-328.
25. Klenk, H. D., R. Rott, M. Orlich, and J. Blodorn. 1975. Activation of influenza A viruses by trypsin treatment. Virology 68:426-439.
26. Lazarowitz, S. G., and P. W. Choppin. 1975. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68:440-454.
27. Mayne, J. T., C. M. Rice, E. G. Strauss, M. W. Hunkapiller, and J. H. Strauss. 1984. Biochemical studies of the maturation of the small Sindbis virus glycoprotein E3. Virology 134:338-357.
28. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Lieberman, J. C. Kosek, G. R. Reyes, and I. L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53:55-67.
29. Mebatsion, T., M. J. Schnell, J. H. Cox, S. Finke, and K. K. Conzelmann. 1996. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. USA 93:7310-4731.
30. Nagai, Y., H. Ogura, and H. Klenk. 1976. Studies on the assembly of the envelope of Newcastle disease virus. Virology 69:523-538.
31. Ohnishi, Y., T. Shioda, K. Nakayama, S. Iwata, B. Gotoh, M. Hamaguchi, and Y. Nagai. 1994. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J. Virol. 68:4075-4079.
32. Ortmann, D., M. Ohuchi, H. Angliker, E. Shaw, W. Garten, and H. D. Klenk. 1994. Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J. Virol. 68:2772-2776.
33. Perez, L. G., and E. Hunter. 1987. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37. J. Virol. 61:1609-1614.
34. Presley, J. F., J. M. Polo, R. E. Johnston, and D. T. Brown. 1991. Proteolytic processing of the Sindhis virus membrane protein precursor PE2 is nonessential for growth in vertebrate cells but is required for efficient growth in invertebrate cells. J. Virol. 65:1905-1909.
35. Russell, D. L., J. M. Dalrymple, and R. E. Johnston. 1989. Sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice. J. Virol. 63:1619-1629.
36. Samson, A. C., and C. F. Fox. 1973. Precursor protein for Newcastle disease virus. J. Virol. 12:579-587.
37. Sanchez, A., M. P. Kiley, B. P. Holloway, and D. D. Auperin. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29:215-240.
38. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
39. Stadler, K., S. L. Allison, J. Schalich, and F. X. Heinz. 1997. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71:8475-8481.
40. Steiner, D. F., S. P. Smeekens, S. Ohagi, and S. J. Chan. 1992. The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267: 23435-23438.
41. Stieneke-Grober, A., M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H. D. Klenk, and W. Garten. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11:2407-2414.
42. Takada, A., C. Robison, H. Goto, A. Sanchez, K. G. Murti, M. A. Whitt, and Y. Kawaoka. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA 94:14764-14769.
43. Takahashi, S., K. Kasai, K. Hatsuzawa, N. Kitamura, Y. Misumi, Y. Ikehara, K. Murakami, and K. Nakayama. 1993. A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells. Biochem. Biophys. Res. Commun. 195:1019-1026.
44. Takahashi, S., T. Nakagawa, K. Kasai, T. Banno, S. J. Duguay, W. J. Van de Ven, K. Murakami, and K. Nakayama. 1995. A second mutant allele of furin in the processing-incompetent cell line, LoVo. Evidence for involvement of the homo B domain in autocatalytic activation. J. Biol. Chem. 270:26565-26569.
45. Volchkov, V. E., S. Becker, V. A. Volchkova, V. A. Ternovoj, A. N. Kotov, S. V. Netesov, and H. D. Klenk. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 214:421-430.
46. Volchkov, V. E., V. M. Blinov, and S. V. Netesov. 1992. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305:181-184.
47. Volchkov, V. E., H. Feldmann, V. A. Volchkova, and H. D. Klenk. 1998. Processing the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95:5762-5767.
48. Webster, R G., and R. Rott. 1987. Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell 50:665-666.
49. Wool-Lewis, R. J., and P. Bates. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.